vancomycin has been researched along with norfloxacin in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (25.76) | 18.7374 |
1990's | 6 (9.09) | 18.2507 |
2000's | 10 (15.15) | 29.6817 |
2010's | 24 (36.36) | 24.3611 |
2020's | 9 (13.64) | 2.80 |
Authors | Studies |
---|---|
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD | 1 |
Brown, NC; Butler, MM; Dix, EJ; Foster, KA; Holm, K; LaMarr, WA; Lamothe, S; Long, ZY; Manikowski, A; Motorina, I; Skow, DJ; Storer, R; Tarantino, PM; Wright, GE; Zhi, C | 1 |
Bae, T; Chen, PR; Duguid, EM; He, C; Rice, PA; Schneewind, O; Williams, WA | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
Hamamoto, H; Kurokawa, K; Lee, BL; Maki, H; Matsuo, M; Murakami, K; Nishida, S; Sekimizu, K; Yamane, N | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Amsler, KM; Bush, K; Foleno, BD; He, W; Lynch, AS; Macielag, MJ; Morrow, BJ | 1 |
Hossion, AM; Iwado, A; Kandahary, RK; Ogawa, W; Otsuka, N; Sasaki, K; Tsuchiya, T; Zamami, Y | 1 |
Duerink, DO; Fluit, AC; Goessens, WH; Hadi, U; Horst-Kreft, D; Kuntaman, K; Lemmens-den Toom, N; Lestari, ES; Pastink, M; Severin, JA; Snijders, SV; van Belkum, A; van Wamel, W; Verbrugh, HA | 1 |
Hossion, AM; Iwado, A; Kandahary, RK; Ogawa, W; Sasaki, K; Tsuchiya, T; Zamami, Y | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Batchu, H; Batra, S; Mishra, A; Shukla, PK; Singh, P; Srivastava, K | 1 |
Aung, TT; Bai, Y; Beuerman, RW; Cao, D; Koh, JJ; Koh, WL; Lakshminarayanan, R; Li, J; Lim, F; Lin, H; Lin, S; Liu, S; Pang, LM; Pervushin, K; Qiu, S; Salleh, SM; Tan, DT; Verma, C; Zhou, L; Zou, H | 1 |
Chopra, S; Kushwaha, P; Modukuri, RK; Pasupuleti, M; Rao, KB; Sashidhara, KV; Shukla, PK; Singh, P; Soni, I | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hong, J; Jung, JH; Kim, A; Kim, MJ; Liu, Y; Noh, TH; Wei, X | 1 |
Aung, TT; Beuerman, RW; Cao, D; Koh, JJ; Lakshminarayanan, R; Li, J; Lim, F; Lin, S; Liu, S; Ren, L; Tan, DT; Verma, C; Wang, L; Wang, Y; Zou, H | 1 |
Aung, TT; Beuerman, RW; Cao, D; Koh, JJ; Lakshminarayanan, R; Lim, F; Lin, S; Liu, S; Ren, L; Sin, WLW; Tan, DTH; Wang, L; Zhou, L | 1 |
Bai, PY; Chu, WC; Cui, DY; Hua, YG; Liu, HM; Liu, Q; Qin, S; Yin, HY; Zhang, E; Zhang, YJ | 1 |
Bai, PY; Chu, WC; Cui, DY; Hua, YG; Qin, S; Yang, QQ; Yang, Y; Yang, ZQ; Zhang, E | 1 |
Gibbons, S; Malkinson, JP; Rahman, MM; Shiu, WKP | 1 |
Bai, PY; Chu, WC; Cui, DY; Hua, YG; Qin, SS; Yang, QQ; Yang, Y; Zhang, E | 1 |
Cai, S; Fang, Z; Guo, Q; Huang, X; Li, Y; Lin, H; Lu, YJ; Sun, N; Tang, Z; Wong, KY; Wong, WL; Yuan, W | 1 |
Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
Caljon, G; Cappoen, D; Claes, P; Cools, F; Cos, P; De Kimpe, N; de Macedo, MB; Delputte, P; Holvoet, F; Maes, L; Mangelinckx, S; Matheeussen, A; Meiresonne, T; Neyrolles, O; Piller, T; Semina, E; Torfs, E; Van Calster, K | 1 |
Majik, MS; Rodrigues, L; Tilve, SG | 1 |
Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH | 1 |
Chen, Y; Fang, S; Li, H; Lin, S; Liu, J; Liu, S; Zhong, R | 1 |
Cai, GX; Gopala, L; Zhang, PL; Zhang, SL; Zhou, CH | 1 |
Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
Chen, F; Chen, J; Ji, L; Liu, F; Qin, Y; Wang, S; Wang, Y; Wu, P; Xue, J | 1 |
Chen, X; Jiang, Q; Kong, Q; Li, G; Wang, Y; Yu, T; Zhang, F | 1 |
Gao, WW; Laiche, MH; Li, YL; Lin, JM; Zhang, PL; Zhou, CH | 1 |
Brazier, JS; Citron, DM; Goldstein, EJ | 1 |
Bercy, P; De Beule, F; Ferrant, A | 1 |
Aloia, MR; Burke, JP; Classen, DC; Elliott, JA; Evershed, S; Ford, CD; Wilfahrt, JK | 1 |
Klastersky, J; Van der Auwera, P | 1 |
Bouanchaud, DH; Huet, Y; Rolin, O | 1 |
Champlin, RE; Gale, RP; Ho, WG; Nakao, SL; Winston, DJ | 1 |
Bartlett, J; Champlin, RE; Deresinski, S; Finley, RS; Ho, WG; Joshi, JH; Karp, J; Levitt, L; Talbot, G; Winston, DJ | 1 |
DiVincenzo, CA; O'Keefe, JP; Tatarowicz, W; Venezio, FR | 1 |
Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M | 1 |
Attisso, MA; Dusart, G; Maillols, H; Simeon de Buochberg, M; Zuccarelli, M | 1 |
Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
Bayer, AS; Greenberg, DP; Yih, J | 1 |
Corrado, ML; Hesney, M; Struble, WE | 1 |
Cox, CE; Grad, C; McCabe, RE | 1 |
Caillon, J; Dellamonica, P; Drugeon, HB | 1 |
Floyd-Reising, SA; Hindler, JA; Kelley, SG; Young, LS | 1 |
Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
Fernández-Roblas, R; Ponte, C; Santamaría, M; Soriano, F; Torres, A | 1 |
DiVincenzo, C; Foster, JK; Lentino, JR; Strodtman, R | 1 |
Benfiguig, K; Eugène, C; Merrer, J; Mitry, E; Tordjman, R | 1 |
Broun, ER; Hromas, RA; Kneebone, PH; Sundblad, K; Tricot, G; Wheat, JL | 1 |
Araj, GF; Zouain, MG | 1 |
Bert, F; Bourdon, N; Le Grand, J; Leflon-Guibout, V; Nicolas-Chanoine, MH | 1 |
Choi, JG; Han, SH; Kang, OH; Keum, JH; Kim, SB; Kim, YG; Kwon, DY; Lee, JH; Mun, SH; Obiang-Obounou, BW; Park, CB; Shin, DW | 1 |
Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
Bao, C; Fan, J; Guo, Y; Liu, Z; Qin, S; Xu, T; Yang, R | 1 |
Dong, L; Gao, F; Liu, Y; Sun, X; Wu, C; Yu, L; Zhang, G; Zhang, J | 1 |
5 review(s) available for vancomycin and norfloxacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Synthetic access to thiolane-based therapeutics and biological activity studies.
Topics: Alkaloids; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Biological Products; Cell Survival; Fungi; Humans; Sesquiterpenes; Sulfhydryl Compounds | 2021 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
[Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review].
Topics: Bacterial Proteins; Bacteriuria; Carbon-Oxygen Ligases; Cecal Diseases; Ceftriaxone; Citrobacter freundii; Codon, Nonsense; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intestinal Perforation; Liver Transplantation; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Norfloxacin; Peritonitis; Postoperative Complications; Staphylococcal Infections; Teicoplanin; Vancomycin; Vancomycin Resistance | 2009 |
4 trial(s) available for vancomycin and norfloxacin
Article | Year |
---|---|
Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Humans; Middle Aged; Mycoses; Norfloxacin; Polymyxins; Random Allocation; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Topics: Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Colistin; Diarrhea; Gastrointestinal Diseases; Humans; Leukemia; Neutropenia; Norfloxacin; Skin Diseases; Sulfamethoxazole; Trimethoprim; Vancomycin | 1988 |
Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Cross Infection; Female; Humans; Lactams; Male; Middle Aged; Norfloxacin; Opportunistic Infections; Random Allocation; Urinary Tract Infections; Vancomycin | 1987 |
Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.
Topics: Acyclovir; Adult; Bacteremia; Bone Marrow Transplantation; Female; Fever; Fluconazole; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Norfloxacin; Penicillins; Premedication; Streptococcal Infections; Vancomycin | 1994 |
57 other study(ies) available for vancomycin and norfloxacin
Article | Year |
---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2005 |
Synthesis and antibacterial activity of 3-substituted-6-(3-ethyl-4-methylanilino)uracils.
Topics: Aniline Compounds; Animals; Anti-Bacterial Agents; DNA Polymerase III; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Uracil | 2005 |
An oxidation-sensing mechanism is used by the global regulator MgrA in Staphylococcus aureus.
Topics: Bacterial Proteins; Cysteine; Hydrogen Peroxide; Oxidation-Reduction; Protein Conformation; Protein Structure, Tertiary; Repressor Proteins; Staphylococcus aureus | 2006 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
Topics: Animals; Anti-Bacterial Agents; Bombyx; Cephalosporins; Chloramphenicol; Cycloserine; Inhibitory Concentration 50; Larva; Microbial Sensitivity Tests; Staphylococcus aureus; Tetracycline; Vancomycin | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Streptococcus pneumoniae | 2010 |
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Drug Design; Enterococcus; Glucosides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quercetin; Vancomycin | 2010 |
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
Topics: Anti-Bacterial Agents; Indonesia; Methicillin; Methicillin Resistance; Phylogeny; Polymerase Chain Reaction; Staphylococcus | 2010 |
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Design; Enzyme Inhibitors; Galactosides; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Targeted Therapy; Quercetin; Rats; Rats, Wistar; Topoisomerase II Inhibitors | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Ethers; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2014 |
Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Cell Membrane; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Rabbits; Structure-Activity Relationship; Unilamellar Liposomes; Xanthones | 2015 |
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
Topics: | 2015 |
Synthesis and antibacterial evaluation of hamacanthin B analogues.
Topics: Anti-Bacterial Agents; Carbon-13 Magnetic Resonance Spectroscopy; Chromatography, High Pressure Liquid; Circular Dichroism; Enterococcus faecalis; Escherichia coli; Indole Alkaloids; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Pyrazines; Stereoisomerism; Structure-Activity Relationship | 2016 |
Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity.
Topics: Animals; Anti-Bacterial Agents; Cornea; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Staphylococcal Infections; Surface-Active Agents; Xanthones | 2017 |
Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA).
Topics: Animals; Anti-Bacterial Agents; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Cell Survival; Drug Resistance, Bacterial; Fibroblasts; Flavones; Hemolysis; Humans; Keratitis; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Mimicry; Rabbits; Staphylococcus aureus; Structure-Activity Relationship | 2017 |
Synthesis and bioactivities study of new antibacterial peptide mimics: The dialkyl cationic amphiphiles.
Topics: Alkylation; Anti-Bacterial Agents; Bacteria; Biofilms; Cell Membrane Permeability; Chemistry Techniques, Synthetic; Drug Resistance, Multiple; Drug Stability; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Peptidomimetics | 2018 |
Synthesis and antibacterial evaluation of novel cationic chalcone derivatives possessing broad spectrum antibacterial activity.
Topics: Anti-Bacterial Agents; Cations; Chalcone; Dose-Response Relationship, Drug; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Salmonella enterica; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Total synthesis of acylphloroglucinols and their antibacterial activities against clinical isolates of multi-drug resistant (MDR) and methicillin-resistant strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Phloroglucinol; Structure-Activity Relationship | 2018 |
Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles.
Topics: Anti-Bacterial Agents; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Surface-Active Agents | 2018 |
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Molecular Structure; Quinolinium Compounds; Structure-Activity Relationship | 2019 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Benzophenanthridines; Cell Line; Dose-Response Relationship, Drug; Humans; Hydrocarbons, Fluorinated; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2019 |
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship | 2021 |
Synthesis and biological evaluation of indole-based peptidomimetics as antibacterial agents against Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Molecular Structure; Peptidomimetics; Structure-Activity Relationship | 2021 |
An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
Topics: Allosteric Regulation; Allosteric Site; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Drug Design; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Docking Simulation; Naphthalimides; Oxidative Stress; Oximes; Penicillin-Binding Proteins; Structure-Activity Relationship | 2022 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Design, synthesis, and biological evaluation of membrane-active honokiol derivatives as potent antibacterial agents.
Topics: Allyl Compounds; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Biphenyl Compounds; Lignans; Mice; Microbial Sensitivity Tests; Phenols | 2022 |
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Biomimetics; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests | 2022 |
An unanticipated discovery of novel naphthalimidopropanediols as potential broad-spectrum antibacterial members.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Mammals; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 2022 |
A selective medium for Fusobacterium spp.
Topics: Culture Media; Erythromycin; Feces; Fusobacterium; Gingiva; Humans; Josamycin; Norfloxacin; Vancomycin | 1991 |
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Immunosuppression Therapy; Ketoconazole; Leukemia; Lymphoma; Miconazole; Norfloxacin; Periodontal Diseases; Periodontal Index; Tooth Loss; Vancomycin | 1991 |
Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Female; Humans; Male; Norfloxacin; Polymyxins; Premedication; Sepsis; Streptococcal Infections; Streptococcus; Tobramycin; Utah; Vancomycin | 1990 |
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Injections, Subcutaneous; Methicillin; Mice; Norfloxacin; Pefloxacin; Penicillin Resistance; Peptides; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin; Virginiamycin | 1986 |
Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Drug Evaluation; Drug Tolerance; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Mycoses; Norfloxacin; Nystatin; Polymyxins; Vancomycin | 1986 |
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.
Topics: Actinomycetales; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Methicillin; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus epidermidis; Ticarcillin; Vancomycin | 1986 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin | 1988 |
[Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
Topics: Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Vancomycin | 1988 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Infective Agents; Endocarditis, Bacterial; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rabbits; Random Allocation; Staphylococcal Infections; Vancomycin | 1988 |
[Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 1987 |
In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Quinolines; Vancomycin | 1987 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.
Topics: Anti-Bacterial Agents; Bacteriuria; Corynebacterium; Humans; Hydrogen-Ion Concentration; Hydroxamic Acids; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Vancomycin | 1987 |
Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gentamicins; Kinetics; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Staphylococcus aureus; Vancomycin | 1986 |
[Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ascitic Fluid; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Norfloxacin; Vancomycin | 1995 |
Antimicrobial resistance of Enterococci in Lebanon.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gentamicins; Humans; Lebanon; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Rifampin; Streptomycin; Teicoplanin; Tetracycline; Vancomycin | 2001 |
In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Load; Benzophenanthridines; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Isoquinolines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Species Specificity; Vancomycin | 2011 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Animals; Anti-Bacterial Agents; Cell Line; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxadiazoles; Rats; Staphylococcal Infections; Structure-Activity Relationship; Vancomycin | 2019 |
Isolation and characterisation of Pulsatilla Radix-utilising bacteria Pediococcus pentosaceus PR-1 from human faeces.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antioxidants; Bile Acids and Salts; Feces; Humans; Kanamycin; Norfloxacin; Pediococcus; Pediococcus pentosaceus; Probiotics; Pulsatilla; Streptomycin; Vancomycin | 2022 |